Macrocycles and Constrained Peptides

2017-11-09T12:42:01+00:00 April 11th, 2013|on Macrocycles, Publications|

Macrocycles and constrained peptides have undergone a rebirth over the last five years in drug discovery, due mainly to the introduction of new approaches for their synthesis and screening. This scientific progress has fueled a burst of business activity, with at least 12 biotech companies in the space, of which almost half were founded in the last 5 years.
Read online article